Close X
Monday, September 23, 2024
ADVT 
Health

Half The World's People To Become Myopic By 2050, Says Study

Darpan News Desk IANS, 18 Feb, 2016 11:15 AM
    Nearly five billion people, that is about half the world's population, are poised to become myopic or short-sighted by the end of 2050, indicates a study.
     
    Also called nearsightedness, myopia is a vision condition in which people can see clearly the objects that are close to eyes but objects far away appear to be blurred to the sight. 
     
    Acting like a silent epidemic, myopia is all set to become the leading cause of permanent blindness globally 
     
    With up to one billion people at an increased risk of blindness, myopia is all set to become the leading cause of permanent blindness globally. 
     
    Further, with the findings suggesting that the US will have 260 million myopes by 2050, up from the 90 million in 2000, and Canada will see 66 million high myopes by 2050, up from the 11 million in 2000, the vision loss from high myopia is expected to increase seven-fold from 2000 to 2050.
     
    The rapid increase in the prevalence of myopia globally is attributed to "environmental factors, lifestyle changes resulting from a combination of decreased time outdoors and increased near work activities, among other factors", said the researchers.
     
    Parents need to ensure that the children's eyes are regularly checked, improve time outdoors and moderate time on near based activities, including electronic devices.
     
    Also, comprehensive eye care services is needed to check the rapid increase in high myopes, along with the development of treatments to control the progression of myopia and prevent people from becoming highly myopic, the researchers suggested in the study published in the journal Ophthalmology revealed.
     
    "We also need to ensure our children receive a regular eye examination from an optometrist or ophthalmologist, preferably each year, so that preventative strategies can be employed if they are at risk," said Kovin Naidoo, a professor at the University of New South Wales in Australia.

    MORE Health ARTICLES

    Estrogen protects some women against heart disease

    Estrogen protects some women against heart disease
    Estrogens, also referred to as female sex hormones, have been thought to protect women from heart diseases and researchers have now found how they do so....

    Estrogen protects some women against heart disease

    How liver can improve diabetes management

    How liver can improve diabetes management
    Finding a way to stimulate glucose accumulation in the liver could help manage diabetes and obesity, shows a new research, paving the way for new...

    How liver can improve diabetes management

    Walnuts can slow down prostate cancer growth

    Walnuts can slow down prostate cancer growth
    “While they (walnuts) are high in fat, their fat does not drive prostate cancer growth. In fact, walnuts do just the opposite when fed to mice,” lead scientist and....

    Walnuts can slow down prostate cancer growth

    Tiny needles hold promise for two key eye diseases

    Tiny needles hold promise for two key eye diseases
    Needles too tiny to be seen with naked eyes can soon deliver drugs to specific areas relevant to two of the world's leading eye diseases - glaucoma and corneal....

    Tiny needles hold promise for two key eye diseases

    New Alzheimer's-related memory disorder found

    New Alzheimer's-related memory disorder found
    Alzheimer's disease now has a new cousin as an international team of researchers has determined criteria for a new neurological disorder called....

    New Alzheimer's-related memory disorder found

    Canada To Do Clinical Trial Of Ebola Vaccine, Far Away From Ebola Researchers

    Canada To Do Clinical Trial Of Ebola Vaccine, Far Away From Ebola Researchers
    TORONTO — A clinical trial of the made-in-Canada Ebola vaccine will be conducted in this country, Health Canada and the Public Health Agency of Canada announced Friday.

    Canada To Do Clinical Trial Of Ebola Vaccine, Far Away From Ebola Researchers